Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Advances in Experimental Medicine and Biology
|
March 1, 2022
Single-Cell Sequencing Technologies in Precision Oncology
David T Melnekoff, Alessandro Laganà
JCO Precision Oncology
|
June 15, 2022
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma
Paula Restrepo, Sherry Bhalla, Yogita Ghodke-Puranik, et al.
Science Advances
|
November 17, 2021
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications
Sherry Bhalla, David T Melnekoff, Adolfo Aleman, et al.
Blood Advances
|
August 26, 2022
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
Tarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, et al.
Blood Cancer Discovery
|
September 16, 2024
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
Santiago Thibaud, Ryan L Subaran, Scott Newman, et al.
Blood
|
November 3, 2022
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, et al.
Blood Neoplasia
|
June 24, 2025
Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma
Rudra P Dutta, Santiago Thibaud, Violetta Leshchenko, et al.
Leukemia & Lymphoma
|
August 20, 2020
A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma
Oliver Van Oekelen, Samir Parekh, Hearn J Cho, et al.
The Journal of Clinical Investigation
|
February 20, 2024
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency
Sarah Aminov, Orsi Giricz, David T Melnekoff, et al.
Blood Advances
|
November 5, 2025
Long-term Remission After Cilta-Cel in Multiple Myeloma Is Linked to Diverse T Cells and Low Myeloid Suppression
Junia Vieira Dos Santos, David T Melnekoff, Adolfo Aleman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Advances in Experimental Medicine and Biology
|
March 1, 2022
Single-Cell Sequencing Technologies in Precision Oncology
David T Melnekoff, Alessandro Laganà
JCO Precision Oncology
|
June 15, 2022
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma
Paula Restrepo, Sherry Bhalla, Yogita Ghodke-Puranik, et al.
Science Advances
|
November 17, 2021
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications
Sherry Bhalla, David T Melnekoff, Adolfo Aleman, et al.
Blood Advances
|
August 26, 2022
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
Tarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, et al.
Blood Cancer Discovery
|
September 16, 2024
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
Santiago Thibaud, Ryan L Subaran, Scott Newman, et al.
Blood
|
November 3, 2022
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, et al.
Blood Neoplasia
|
June 24, 2025
Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma
Rudra P Dutta, Santiago Thibaud, Violetta Leshchenko, et al.
Leukemia & Lymphoma
|
August 20, 2020
A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma
Oliver Van Oekelen, Samir Parekh, Hearn J Cho, et al.
The Journal of Clinical Investigation
|
February 20, 2024
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency
Sarah Aminov, Orsi Giricz, David T Melnekoff, et al.
Blood Advances
|
November 5, 2025
Long-term Remission After Cilta-Cel in Multiple Myeloma Is Linked to Diverse T Cells and Low Myeloid Suppression
Junia Vieira Dos Santos, David T Melnekoff, Adolfo Aleman, et al.
Page
of 2